Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing.


Journal

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
ISSN: 1815-7920
Titre abrégé: Int J Tuberc Lung Dis
Pays: France
ID NLM: 9706389

Informations de publication

Date de publication:
01 05 2019
Historique:
entrez: 18 5 2019
pubmed: 18 5 2019
medline: 5 3 2020
Statut: ppublish

Résumé

<sec id="st1"> <title>OBJECTIVE</title> To conduct a multicentre study to establish the critical concentration (CC) for clofazimine (CFZ) for drug susceptibility testing (DST) of

Identifiants

pubmed: 31097068
doi: 10.5588/ijtld.18.0417
doi:

Substances chimiques

Antitubercular Agents 0
Clofazimine D959AE5USF

Types de publication

Journal Article Multicenter Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

594-599

Auteurs

N A Ismail (NA)

Centre for Tuberculosis, National Institute of Communicable Diseases, South Africa Division of National Health Laboratory Services, Johannesburg, Department of Medical Microbiology, University of Pretoria, Pretoria, Department of Internal Medicine, University of Witwatersrand, Johannesburg, South Africa.

H M Said (HM)

Centre for Tuberculosis, National Institute of Communicable Diseases, South Africa Division of National Health Laboratory Services, Johannesburg.

C Rodrigues (C)

P D Hinduja National Hospital and Medical Centre, Mumbai.

S V Omar (SV)

Centre for Tuberculosis, National Institute of Communicable Diseases, South Africa Division of National Health Laboratory Services, Johannesburg.

K Ajbani (K)

P D Hinduja National Hospital and Medical Centre, Mumbai.

N Sukhadiad (N)

Becton Dickinson India Pvt Ltd, Mumbai, India.

T A Kohl (TA)

National Reference Centre for Mycobacteria, Forschungszentrum Borstel, Borstel, Germany.

S Niemann (S)

National Reference Centre for Mycobacteria, Forschungszentrum Borstel, Borstel, Germany.

K Kranzer (K)

National Reference Centre for Mycobacteria, Forschungszentrum Borstel, Borstel, Germany.

M Diels (M)

Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp.

L Rigouts (L)

Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

S Rüsch-Gerdes (S)

National Reference Centre for Mycobacteria, Forschungszentrum Borstel, Borstel, Germany, Department of Medical Microbiology, University of Pretoria, Pretoria.

S Siddiqi (S)

Becton Dickinson and Company, Franklin, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH